Inventor · disambiguated record
Simeon Bowers
Also filed as: BOWERS SIMEON
25 granted patents·22 pending applications·47 citations·filing 2005–2024
94Inventor score
Files withSRX CARDIO LLC11IMAGO PHARMACEUTICALS INC10ELAN PHARM INC7ONYX THERAPEUTICS INC4GALEMMO ROBERT A2
Top patents by PatentIndex Score
47 records- 0195US10980801B2Phenylpiperazine proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators and their useSRX CARDIO LLC·Filed 2020·Granted Apr 20, 2021·6 cites·15 claims
- 0292US10865185B2Composition and methods of use of tetrahydroisoquinoline small molecules to bind and modulate PCSK9 protein activitySRX CARDIO LLC·Filed 2016·Granted Dec 15, 2020·5 cites·8 claims
- 0392US10568882B2Phenylpiperazine proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators and their useSRX CARDIO LLC·Filed 2016·Granted Feb 25, 2020·6 cites·13 claims
- 0490US9434761B2Tripeptide epoxy ketone protease inhibitorsONYX THERAPEUTICS INC·Filed 2014·Granted Sep 6, 2016·13 cites·20 claims
- 0589US10821106B2Composition and methods of use of novel phenylalanine small organic compounds to directly modulate PCSK9 protein activitySRX CARDIO LLC·Filed 2016·Granted Nov 3, 2020·4 cites·11 claims
- 0680US7858642B2Substituted hydroxyethylamine aspartyl protease inhibitorsELAN PHARM INC·Filed 2009·Granted Dec 28, 2010·5 cites·24 claims
- 0780US2024415830A1Composition and methods of use of novel phenylalanine small organic compounds to directly modulate pcsk9 protein activitySRX CARDIO LLC·Filed 2024·Application pending·0 cites
- 0879US10647744B2Tripeptide epoxy ketone protease inhibitorsONYX THERAPEUTICS INC·Filed 2016·Granted May 12, 2020·2 cites·38 claims
- 0977US7754712B2Bridged N-cyclic sulfonamido inhibitors of gamma secretaseELAN PHARM INC·Filed 2007·Granted Jul 13, 2010·2 cites·27 claims
- 1077US2022081427A1Inhibitors of jun n-terminal kinaseIMAGO PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1176US7345056B2Bridged N-cyclic sulfonamido inhibitors of gamma secretaseELAN PHARM INC·Filed 2006·Granted Mar 18, 2008·2 cites·20 claims
- 1270US11925637B2Phenylpiperazine proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators and their useSRX CARDIO LLC·Filed 2021·Granted Mar 12, 2024·0 cites·17 claims
- 1370US9073891B2Inhibitors of Jun N-terminal kinaseSHAM HING L·Filed 2012·Granted Jul 7, 2015·1 cites·6 claims
- 1470US2020277285A1Inhibitors of jun n-terminal kinaseIMAGO PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1569US11944619B2Phenylalanine small organic compounds to directly modulate PCSK9 protein activitySRX CARDIO LLC·Filed 2020·Granted Apr 2, 2024·0 cites·17 claims
- 1669US11078233B2Tripeptide epoxy ketone protease inhibitorsONYX THERAPEUTICS INC·Filed 2020·Granted Aug 3, 2021·0 cites·27 claims
- 1768US2020039972A1Inhibitors of jun n-terminal kinaseIMAGO PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1867US11945782B2Composition and methods of use of tetrahydroisoquinoline small molecules to bind and modulate PCSK9 protein activitySRX CARDIO LLC·Filed 2020·Granted Apr 2, 2024·0 cites·5 claims
- 1967US2019194176A1Inhibitors of jun n-terminal kinaseIMAGO PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2065US2018319780A1Inhibitors of jun n-terminal kinaseIMAGO PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2163US11891369B2Compounds for binding proprotein convertase subtilisin/kexin type 9SRX CARDIO LLC·Filed 2020·Granted Feb 6, 2024·0 cites·5 claims
- 2263USRE47302EPeptide epoxyketone immunoproteasome inhibitorsONYX THERAPEUTICS INC·Filed 2017·Granted Mar 19, 2019·0 cites·31 claims
- 2363US2015087826A1Spirocyclic digydro-thiazine and dihydro-oxazine bace inhibitors, and compositions and uses thereofXU YING-ZI·Filed 2014·Application pending·0 cites
- 2463US2015087825A1Spirocyclic digydro-thiazine and dihydro-oxazine bace inhibitors, and compositions and uses thereofXU YING-ZI·Filed 2014·Application pending·0 cites
- 2563US2018037577A1Inhibitors of jun n-terminal kinaseIMAGO PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 2662US9796706B2Inhibitors of Jun N-terminal kinaseIMAGO PHARMACEUTICALS INC·Filed 2016·Granted Oct 24, 2017·0 cites·17 claims
- 2759US2013231335A1Inhibitors of polo-like kinaseELAN PHARM INC·Filed 2013·Application pending·0 cites
- 2859US2013331376A1Inhibitors of polo-like kinaseELAN CORP INC·Filed 2013·Application pending·0 cites
- 2958US9884828B2Substituted cinnolines as inhibitors of LRRK2 kinase activityAUBELE DANIELLE L·Filed 2012·Granted Feb 6, 2018·1 cites·23 claims
- 3057US9493485B2Spirocyclic dihydro-thiazine and dihydro-oxazine BACE inhibitors, and compositions and uses thereofIMAGO PHARMACEUTICALS INC·Filed 2013·Granted Nov 15, 2016·0 cites·19 claims
- 3156US2015259330A1Inhibitors of jun n-terminal kinaseIMAGO PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 3254US12115154B2Compounds for the modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9)SRX CARDIO LLC·Filed 2020·Granted Oct 15, 2024·0 cites·7 claims
- 3353US8450363B2Inhibitors of Jun N-terminal kinaseSHAM HING L·Filed 2010·Granted May 28, 2013·0 cites·25 claims
- 3453US2019119236A1Compounds for binding proprotein convertase subtilisin/kexin type 9 (pcsk9)PORTOLA PHARM INC·Filed 2017·Application pending·0 cites
- 3553US2016272654A1Spirocyclic dihydro-thiazine and dihydro-oxazine bace inhibitors, and compositions and uses thereofIMAGO PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 3652US2015126502A1Inhibitors of polo-like kinaseELAN PHARM INC·Filed 2015·Application pending·0 cites
- 3751US8541418B2Inhibitors of polo-like kinaseGALEMMO ROBERT A·Filed 2010·Granted Sep 24, 2013·0 cites·14 claims
- 3851US8445503B2Inhibitors of polo-like kinaseGALEMMO ROBERT A·Filed 2010·Granted May 21, 2013·0 cites·9 claims
- 3951US8283358B2N-sulfonamido polycyclic pyrazolyl compoundsKONRADI ANDREI W·Filed 2009·Granted Oct 9, 2012·0 cites·24 claims
- 4051US2022267269A1Compounds for the modulation of proprotein convertase subtilisin/kexin type 9 (pcsk9)SRX CARDIO LLC·Filed 2020·Application pending·0 cites
- 4150US7977368B2Pyrazolopyrrolidines as inhibitors of gamma secretaseELAN PHARM INC·Filed 2008·Granted Jul 12, 2011·0 cites·9 claims
- 4248US2011003802A1Bridged N-Cyclic Sulfonamido Inhibitors of Gamma SecretaseELAN PHARM INC·Filed 2010·Application pending·0 cites
- 4342US2007149525A1Methods of treating amyloidosis using aryl-cyclopropyl derivative aspartyl protease inhibitorsHOM ROY·Filed 2006·Application pending·0 cites
- 4442US2005239836A1Substituted hydroxyethylamine aspartyl protease inhibitorsJOHN VARGHESE·Filed 2005·Application pending·0 cites
- 4538US2019209704A1Novel antibody-drug conjugates and related compounds, compositions and methods of useIGENICA BIOTHERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 4637US2012115848A1Inhibitors of Polo-Like KinaseGALEMMO JR ROBERT A·Filed 2011·Application pending·0 cites
- 4735US2005239832A1Methods of treatment of amyloidosis using bi-cyclic aspartyl protease inhibitorsJOHN VARGHESE·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Simeon Bowers files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →